Skip Nav Destination
About the Journal
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms.. Read More About the Journal
Impact Factor
6.261
Featured Articles
Trending - Altmetric
GAS6-AXL inhibition by AVB-500 overcomes resistance to paclitaxel in endometrial cancer by decreasing tumor cell glycolysis
Last mentioned on Thursday May 19 2022
Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells
Last mentioned on Friday May 20 2022
Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor
Last mentioned on Friday May 20 2022
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
Last mentioned on Friday May 20 2022
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma
Last mentioned on Friday May 20 2022